During cancer development, DHCR24 has been demonstrated to be aberrantly expressed in various cancers, including metastatic melanoma, bladder cancer, and salivary adenoid cystic carcinoma [22–24], although its specific mechanisms in OC remain to be fully elucidated. This evidence concerns the gene DHCR24 and cancer.